• Most Popular
  • Most Shared

Helicos sets IPO at 5.4 mln shares, $13-$15

Mon May 7, 2007 5:46pm EDT

WASHINGTON, May 7 (Reuters) - Helicos BioSciences Corp., a genetic analysis technologies firm, set its planned initial public offering on Monday at 5.4 million shares at between $13 and $15 per share.

Regulatory News  |  Bonds  |  IPOs

The underwriters, led by UBS Investment Bank, will have the option to buy another 810,000 shares to cover overallotments, according to an amended offering document filed with the U.S. Securities and Exchange Commission.

The Cambridge, Massachusetts-based company said it is seeking a Nasdaq listing under the symbol "HLCS."

Regulatory News
Bonds
IPOs


More from Reuters

Photo

Tech solutions to climate change

Experts say there is no single answer to solving global warming, but a handful of technologies could be promising. Check out some of the candidates and join the debate.  Full Article 

    Climate conference
    Onlookers gather outside the historic Federal Hall where U.S. President Barack Obama is speaking in the heart of Wall Street in New York September 14, 2009. REUTERS/Larry Downing

    One step closer to reform

    The House of Representatives approved the biggest changes in financial regulation since the Great Depression, marking a win for the Obama administration and congressional Democrats.  Full Article 

    Regulatory News
    The share price index DAX board is seen in front of an emergency exit sign at Frankfurt's stock exchange, October 8, 2008. REUTERS/Kai Pfaffenbach

    "Deflation is with us"

    Fear of the market abyss has faded for investors, but another fear is lurking on the horizon, if not already here.  Full Article 

    Investment Outlook Summit